| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 21,855 | 30,252 | 21,314 | 29,018 | | Cost of Revenue | 10,340 | 29,752 | 17,676 | 13,216 | | | Gross Profit | 11,515 | 500 | 3,638 | 15,802 | | | Operating Expenses | | Research Development | 1,944 |
-
|
-
|
-
| | Selling General and Administrative | 9,857 | (149) | 5,267 | 17,758 | | Non Recurring |
-
|
-
|
-
| 3,525 | | Others | 389 | 388 | 407 | 773 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (676) | 261 | (2,036) | (6,255) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (5,131) | (52) | 27 | 118 | | Earnings Before Interest And Taxes | (2,701) | (4,792) | (95) | (6,369) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (2,701) | (4,792) | (95) | (6,369) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
| (3) | 3 | 16 | | | | Net Income From Continuing Ops | (788) | (4,796) | (92) | (6,272) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| (351) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (348) | (4,796) | (92) | (6,623) | | Preferred Stock And Other Adjustments | (1) | 1 |
-
|
-
| | | Net Income Applicable To Common Shares | ($349) | ($4,795) | ($92) | ($6,623) |
|
0.31% Nasdaq 0.00%
Income Statement
